ULTRALIFE CORP (ULBI) - Form 8-K Summary
Business Context and Reporting Period
Ultralife Corporation, a Delaware corporation, filed this Current Report on Form 8-K on May 9, 2025. The filing serves to announce the financial results for the first quarter ended March 31, 2025. The company's common stock trades on the NASDAQ Stock Market under the symbol ULBI.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. Item 2.02 states that these results are detailed in a press release attached as Exhibit 99.1, which is incorporated by reference but not included in the provided text.
Material Changes
The filing does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Risks
This 8-K filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. Such information is expected to be contained within the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 9, 2025) for actual Q1 2025 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any updated full-year guidance or operational outlook provided in the press release.
- Confirm the absence of any unusual items or restatements in the full press release text.